Cite
HARVARD Citation
Sandborn, W. et al. (2010). Anti-CD3 antibody visilizumab is not effective in patients with intravenous corticosteroid-refractory ulcerative colitis. Gut. 59 (11), pp. 1485-1492. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sandborn, W. et al. (2010). Anti-CD3 antibody visilizumab is not effective in patients with intravenous corticosteroid-refractory ulcerative colitis. Gut. 59 (11), pp. 1485-1492. [Online].